Core Points - Meihua International Medical Technologies Co., Ltd. announced a reverse share split at a ratio of 1-for-100, effective November 24, 2025, to comply with Nasdaq's minimum bid price requirement of $1.00 per share [1][2][4] Group 1: Reverse Share Split Details - The reverse share split will change the par value of Class A ordinary shares from $0.0005 to $0.05 per share [2] - The number of issued and outstanding Class A ordinary shares will decrease from approximately 56 million to approximately 0.56 million [4] - No fractional shares will be issued; fractional interests will be rounded up to the nearest whole number [3] Group 2: Shareholder Information - VStock Transfer, LLC is designated as the exchange agent and will provide instructions to shareholders regarding the exchange of share certificates [5][6] - Shareholders holding shares in book-entry form or brokerage accounts do not need to take any action for the reverse share split [5] Group 3: Company Overview - Meihua is a manufacturer of Class I, II, and III disposable medical devices, with over 1,000 products for domestic sales and more than 120 products exported to over 30 countries [7] - The company has received international "CE" certification and ISO 13485 system certification, and is registered with the FDA for over 20 Class I products [7]
Meihua International Announces 1-For-100 Reverse Share Split